1 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Pan American Foot-and-Mouth Disease Center PANAFTOSA - VETERINARY PUBLIC HEALTH
2 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Dr. Ottorino Cosivi Dr. Ottorino Cosivi Director – Panaftosa-PAHO/WHO TITULO
3 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (1) COSALFA 41 PANAFTOSA organized the 41 st South American Commission for the Fight Against Foot-and-Mouth Disease (COSALFA) was held last April in Lima, Peru. This conference counted with the participation of the represented by their highest authorities in animal health and by the private sector, with representatives from 12 countries from South America and Panama. The clinical presentation of the FMD has declined dramatically with no clinical reports of disease for over two years. In this context of absence of clinical occurrence, major challenges arise for the surveillance strategies carried by the health authorities.
4 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (1) COSALFA 41 reviewed and defined guidelines regarding the opportunities and challenges the region is facing, to maintain and expand the success achieved in this Region in relation to foot-and-mouth disease. The main resolutions approved in the conference were focused on: ⁻the creation of a FMD regional antigen bank; ⁻renewing the support and political commitment of countries to the objectives of the Hemispheric Program for the Eradication of Foot-and-Mouth Disease (PHEFA); ⁻the possibility of carrying out a Hemispheric Committee for the Eradication of Foot- and-Mouth Disease (COHEFA) extraordinary meeting in 2014; ⁻approving the biennial plan 2014/2015 for PANAFTOSA; ⁻the admission of Surinam as country member of the COSALFA.
5 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (2) TECHNICAL COOPERATION IN BOLIVIA PANAFTOSA carry on providing full support to Bolivia by the deployment in the country of a member of staff to provide permanent technical cooperation. In 2013, the country carried out a Serological survey to detect antibodies against FMDV aiming to demonstrate absence of infection in the departments of Beni and Pando. ⁻PANAFTOSA is accompanied all the steps of the study: in the study design, in its execution (including field and laboratory support) and in the interpretation of the results. Field simulation exercise on FMD outbreak response performed in the Department of Beni in November 2013, along with Paraguay and Uruguay technicians.
6 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (2) TECHNICAL COOPERATION IN PARAGUAY Training course of Epidemiology, Care for Health Emergencies and vaccination strategy against FMD, with participation of 53 professionals SENACSA and private sector of Paraguay.
7 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (3) TECHNICAL COOPERATION IN ECUADOR In 2014, the country is carrying out a serological survey to detect antibodies against FMDV in Ecuador utilizing a targeted surveillance strategy aiming to demonstrate absence of infection; PANAFTOSA is accompanying Ecuador in all the steps: in the study design, in its execution (including field and laboratory support) and in the interpretation of the results. The study meets the targeted surveillance concept described in the OIE Code, i.e. the increased likelihood of infection in particular locations, where there is the presence of potential risks.
8 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (3) Study design coverts the following points: ⁻Definition of the epidemiological areas according to geographical, production and animals movements patterns characteristics. ⁻Identification of the risk distribution (low and high) across local administrative divisions utilizing the national databases available in Ecuador (Census and animal movements records) together with the historical records for the last episodes of FMD. ⁻Sample size calculation utilizing a two-stage strategy based on herd sensitivity (that expresses the relationship between herd size and the number of farms to be sampled). ⁻Farms random selection.
9 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO MAIN COOPERATION PROJECTS ON FMD IN THE COUNTRIES 2013/14 (4) CAF PROJECT - PERU AND ECUADOR BORDERS Panaftosa, under the Technical Cooperation Project with the Andean Development Corporation (CAF), targeted a cooperation action in the southern border of Ecuador and northern Peru with the aim of establishing health studies in the area based on a characterization of risk, allowing the advancement of epidemiological free FA border including departments that border Ecuador Peru. In this framework, in November 2013 in the city of Machala, Ecuador, the Workshop on Risk Characterization and Population Dynamics studies Bovine Foot in order to bring awareness to professionals local units in the border region on the importance of the characterization and assessment of status of FMD. The project capacitation project continues over 2014 through as series of practical exercises and workshops.
10 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO PAHO VPH Activities in the Caribbean SUBREGIONAL WORKSHOP “One Health: From Ideas to Actions” organised in Trinidad and Tobago in February 2013. Participation from Ministries of Health, Agriculture (veterinary services) and Environment of 8 Caribbean countries, as well as OIE, FAO, USDA-APHIS, CARPHA, CABI. Participants agreed to advocate for One Health approach in their countries. ONE HEALTH POLICY FOR CARICOM DEVELOPED BY PAHO AND FAO. Endorsed by CaribVET Steering Committee, CARICOM Chief Veterinary Officers, CARICOM Ministers of Agriculture in 2013. Endorsed by CARICOM Chief Medical Officers in April 2014, will be discussed by CARICOM Ministers of Health in September 2014.
11 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO PAHO VPH Activities in the Caribbean PROJECT “One Health, One Caribbean, One Love” has been approved by European Union ACP Secretariat for Euro 1.2 million. Project began on March 1, 2014 and will be implemented over 36 months by the University of the West Indies, PAHO/WHO, FAO, and CIRAD. Project will train first responders in the recognition of foreign animal diseases, strengthen veterinary laboratories by introducing isothermal “lamp” technology, interlaboratory proficiency testing, and quality assurance. It will also conduct a One Health Leadership Series and develop a One Health network and strategic plan for the Caribbean. IN APRIL 2013, convened a meeting on Brucellosis for senior decision makers from Ministries of Agriculture and Health of Trinidad and Tobago. This led to the creation of a cabinet appointed task force on zoonotic diseases. IN JUNE 2013, organised subregional food safety workshop for Caribbean countries in Guyana.
12 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO PAHO VPH Activities in the Caribbean ORGANISED AND SPONSORED MEETING OF CARIBVET VETERINARY PUBLIC HEALTH working group in Roseau, Dominica in September 2013. Participants did root cause analysis of Leptospirosis in the Caribbean and formulated One Health guidelines for prevention, surveillance and control. VPH working group currently developing public awareness materials to prevent Leptospirosis in general public, dog owners and livestock owners. IN NOVEMBER 2013, organised and sponsored a subregional workshop on including food safety and nutrition considerations in national emergency plans for Caribbean countries. IN JULY 2014, CaribVET VPH working group will conduct training on rabies diagnostics for veterinary diagnostic laboratory personnel from Grenada, Guyana, Suriname and Trinidad and Tobago.
13 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO EPIDEMIOLOGY AND SURVEILLANCE FOODBORNE DISEASES BURDEN OF ILLNESS STUDIES Completed and published special issue for Caribbean studies Vol. 31 No. 4 Dec 2013 (Suppl 1). Completed study in Colombia (pilot in selected departments) RISK ANALYSIS Subregional Workshop for capacity building in Risk Management Strategies for Salmonella spp. in Poultry (Central American countries plus Belize, Mexico, Dominican Republic and Cuba.)
14 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO EPIDEMIOLOGY AND SURVEILLANCE FOODBORNE DISEASES INTEGRATED SURVEILLANCE FOR ANTIMICROBIAL RESISTANCE Subregional Project defined and approved by national authorities for Peru, Bolivia, Ecuador and Colombia (waiting for funding) National workshops in Brazil and Mexico (national programs definition) National program consolidated in Colombia National pilot projects finished in Paraguay, Argentina, Uruguay (all in the poultry chain) National on-going project in Costa Rica (pig chain)
15 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO 154 labs - 30 countries. INTER-AMERICAN NETWORK OF FOOD ANALYSIS LABORATORIES (INFAL)
16 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO ZOONOSIS HEALTH SECTOR FIRST LEVEL OF ATTENTION IN CENTRAL AMERICAN countries with capacity in clinical and epidemiological diagnosis for Brucellosis, Zoonotic Tuberculosis (M bovis) and Leptospirosis. HEALTH SECTOR NATIONAL REFERENCE LABORATORIES with capacity in diagnosis in Brucellosis and Zoonotic Tuberculosis (M bovis )and Leptospirosis. GUIDELINES FOR SURVEILLANCE and response for equine encephalitis (human and animals sectors)
17 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
18 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Título de la presentación17
19 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
20 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
21 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
22 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
23 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Enfermedades Desatendidas y relacionas con la pobreza…
24 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Afectan a los población carenciada (rural, urbana o suburbana), pueblos indígenas y minorías étnicas Afectan a los población carenciada (rural, urbana o suburbana), pueblos indígenas y minorías étnicas Afectan principalmente a personas sin acceso adecuado a servicios de salud, educación, agua segura y saneamiento, deficiencias de infraestructura en la vivienda y en el ambiente, mal nutrición. Afectan principalmente a personas sin acceso adecuado a servicios de salud, educación, agua segura y saneamiento, deficiencias de infraestructura en la vivienda y en el ambiente, mal nutrición. Por compartir determinantes sociales y ambientales comunes, las EID pueden presentan superposición geográfica Por compartir determinantes sociales y ambientales comunes, las EID pueden presentan superposición geográfica Eliminar las EIDs es un imperativo moral. Eliminar las EIDs es un imperativo moral. Enfermedades Infecciosas Desatendidas (EID)
25 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO ● Son enfermedades agudas y crónicas con impacto en todo el ciclo vital. ● Niñas/niños Afectan negativamente el desarrollo físico y mental, disminuyendo la capacidad de aprendizaje y afectando la asistencia escolar. Afecta los resultados del embarazo, peso al nacer y la supervivencia neonatal ● Adultos Reduce la productividad laboral y ingresos. En algunos casos crean estigma social Discapacidad y muerte prematura El combate a las EID es una de las mayores dificultades que deben superarse para cumplir los Objetivos de Desarrollo del Milenio relacionados con la disminución de las enfermedades infecciosas (ODM 6) y reducción de la pobreza (ODM 1) Enfermedades Infecciosas Desatendidas (EID)
26 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
27 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Clasificación de las EID y otras infecciones relacionadas con la pobreza (Resolución OPS CD49.R19) En la Resolución CD49.R19 del Consejo Directivo de la OPS sobre “Eliminación de las Enfermedades desatendidas y otras infecciosas relacionadas con la pobreza” fueron incluidas 12 enfermedades infecciosas desatendidas con el objetivo de eliminarlas o reducir significativamente su impacto para el año 2015.
28 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO CRITERIOS DE SELECCIÓN DE LAS ENFERMEDADES Agenda inconclusa Agenda inconclusa Factibilidad técnica: disponibilidad de conocimientos e instrumentos Factibilidad técnica: disponibilidad de conocimientos e instrumentos Datos fidedignos regionales acerca de la factibilidad de eliminación Datos fidedignos regionales acerca de la factibilidad de eliminación Criterios económicos Criterios económicos Carga de morbilidad desigual Carga de morbilidad desigual Importancia política: debe reconocerse como un problema de salud pública Importancia política: debe reconocerse como un problema de salud pública Mejores prácticas Mejores prácticas
29 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Grupo 1: Enfermedades Infecciosas Desatendidas con metas de eliminación. Filariasis linfática Oncocercosis Tracoma Enfermedad de Chagas Rabia humana transmitida por perros Peste Lepra/Hanseniasis Malaria Tétanos neonatal Sífilis congénita
30 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Grupo 2: Enfermedades cuya carga puede reducirse drásticamente con los instrumentos actuales. Esquistosomiasis Esquistosomiasis Helmintiasis transmitidas por el suelo.
31 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Es necesario: Aumentar la investigación operativa Evaluar los instrumentos nuevos Mejorar los sistemas de vigilancia. Otras Enfermedades de importancia en la Región Leishmaniasis Leptospirosis Equinococosis quistica/Hidatidosis Cisticercosis Otras parasitosis Contar con datos de prevalencia que permitan la comparación para apoyar metas de eliminación.
32 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Rabia Humana Transmitida por el Perro
33 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
34 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
35 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Numero de años con evidencia de peste durante el periodo, America Latina, 1899 - 2012 1899 -1949 1950 -19791980 -2012 Fuente: PAHO/HSD/IR
36 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
37 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Escenario – Leishmaniasis Tegumentar 2006-2010: 296.005 casos Media anual : 59.201 casos Región Andina: 49,1% (145.248) casos Región CONOSUR: 37,5% (110.959) casos Región Centro América:13,4%(39.798) casos Fuente: OPS/WHO- disponibles por los programas de control de leishmaniasis de los países Elaboración cartográfica: OPS/HSD/IR, octubre 2011 C asos de leishmaniasis tegumentar, media anual de casos, Américas, 2006-2010
38 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO 2006-2010: 19.359 casos Média anual : 3.872 casos Região CONOSUR: 98% - 3.794 casos Região Andina: 1,75% - 72 casos Região Centro América:0,5% - 6 casos Fuente: OPS/WHO- disponibles por los programas de control de leishmaniasis de los paísesElaboración cartográfica: OPS/HSD/IR, octubre 2011 Casos de leishmaniose tvisceral segundo média anual de casos, Américas, 2006-2010 Escenario – Leishmaniasis Visceral
39 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
40 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Control de la Hidatidosis Cisticercosis Fasciola
41 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Preparación del Seminario Reunión de Planificación para desarrollo Plan Nacional Intersectorial
42 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO
43 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO LABORATORIO DE REFERENCIA ÁREAS de COOPERACIÓN TÉCNICA Referencia diagnóstica Vacunas - PROYECTO BANCO REGIONAL de ANTIGENOS/VACUNAS Distribución de patrones de referencia Fortalecimiento de la Calidad de laboratorios de los países de la región: ⁻Organización de ejercicios de proficiencia ⁻Capacitación de recursos humanos ⁻Asesoría técnica directa Armonización/implementación de metodologias de diagnóstico
44 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO LABORATORIO DE REFERENCIA Fortalecimiento de Calidad de Laboratorios de la Región ORGANIZACIÓN EJERCICIOS DE PROFICIENCIA - 2014 ⁻Detección de antigeno de virus vesiculares ⁻Detección de anticuerpos para fiebre aftosa FORMACIÓN DE RECURSOS HUMANOS ⁻Calendario Intramural de Capacitación 2014 4 modulos de Capacitación - www.paho.org/panaftosa ⁻Asesoría técnica directa
45 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO tit nn
46 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO tit nn
47 PANAFTOSA Pan American Foot-and-Mouth Disease Center Veterinary Public Health PAHO WHO Twitter/panaftosa_inf Facebook/PANAFTOSA – OPS/OMS [email protected] www.paho.org/panaftosa